SLC26A4 and chronic obstructive pulmonary disease: The current work confirms a role for Slc26a4, most likely as a means of coordinating the expression of MUC5AC, a major product of mucus abundantly expressed during COPD progression, and further implicates a role for RAGE in its activity.